Literature DB >> 215374

Long-term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor.

H R Brunner, H Gavras, G A Turini, B Waeber, P Cappuis, D N McKinstry.   

Abstract

1. Captopril or SQ 14 225, administered orally twice a day, reduced the blood pressure of hypertensive patients whatever their clinical diagnosis and even when their plasma renin activity was 'normal' or low. 2. Long-term administration of captopril, either alone or together with diuretics, provides a powerful new tool with which to treat ambulatory hypertensive patients. 3. The renin system may play an important role in maintaining blood pressure in a majority of hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215374     DOI: 10.1042/cs055293s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  6 in total

Review 1.  Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension. An overview.

Authors:  C M Ferrario
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Recent advances in evaluation and management of childhood hypertension.

Authors:  M J Dillon
Journal:  Eur J Pediatr       Date:  1979-11       Impact factor: 3.183

3.  Long-term captopril treatment in moderate to severe hypertension.

Authors:  A Santucci; F Aguglia; G De Mattia; C Ficara; F Balsano
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Aldosterone mediates the changes in hexose transport induced by low sodium intake in chicken distal intestine.

Authors:  C Garriga; J M Planas; M Moretó
Journal:  J Physiol       Date:  2001-08-15       Impact factor: 5.182

Review 5.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 6.  Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy.

Authors:  Christoph Schindler; Peter Bramlage; Wilhelm Kirch; Carlos M Ferrario
Journal:  Vasc Health Risk Manag       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.